MAY 16, 2018 06:30 AM PDT

Ketogenic Diet Has Anti-Tumor Effects

What is up with the ketogenic diet?  Individuals struggling with their size and health have utilized it successfully to lose large amounts of weight in relatively short spans of time.  The ketogenic diet (KD) is a high-fat, low-carbohydrate, moderate-protein method of eating to utilize the body’s ability to use fat for energy, rather than using consumed glucose in multiple forms including carbohydrates.  The body enters a state of ketosis whereby body fat is burned for cellular energy and produces ketones.  After learning more about this eating method, researchers began to look at the biochemical mechanisms of this ketogenic process in the body; the impact on cells is very positive.  Healthy cells can produce ATP via oxidative phosphorylation instead of via glycolysis.  Cancerous cells, on the other hand, cannot generate energy without the glycolytic pathway and thus, do not produce the energy needed to survive in the KD environment.  The Warburg effect outlines the biochemical phenomenon where cancer cells use glycolysis to produce energy rather than alternative methods of ATP production.  It is postulated that the Warburg Effect supports the biosynthetic requirements of uncontrolled proliferation, according to Liberti and Locasale (Trends Biochem Sci, 2016).  Cancerous cells have also been shown to have an inability to process ketone bodies due to mitochondrial dysfunction.  The KD can therefore be a dietary option for cancer patients to reduce their blood glucose levels, thus starving cancerous cells of their energy source.  In addition, lowering blood glucose levels triggers lowered levels of insulin and growth factors which have been shown to be drivers in cancer progression resulting in energy depleted cancer cells with low drive to proliferate and grow.

One study published this year in the journal Aging outlined their proposal and evaluation of preclinical study data on this topic.  The literature supports the hypothesis that a KD can have an anti-tumor effect, but it may be dependent on the type of cancer involved. KD has been studied with neuroblastoma patients and been shown to reduce growth rates.  One study suggested the difficulty in utilizing a KD in some cancer patients with cachexia so proposed an alternative KD diet, termed ad libitum KD with 25% medium-chain triglycerides and 75% long-chain triglycerides produced a better anti-tumor effect.  Individual optimization may be necessary for a provider and patient based on their cancer diagnosis and tumor profile.  With the use of data analytics and computational oncology to provide toolkits and databases for tumor profiles and precision medicine suggestions, this information could also be included.

Randomized clinical trials have not been completed to evaluate this approach but of the clinical studies in the literature, results are promising and something to consider for patients.

This TedTalk is done by a researcher in Florida who is currently working on ketogenic agents and alternative energy sources to reduce cancer load. 

Sources: Aging, Trends in Biochemical Science, Redox Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
OCT 29, 2018
Neuroscience
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Re-sensitizing Drug-resistant Human Tumor Cells
Understanding how cancer cells avoid death despite their DNA being damaged will create new strategies to enhance cancer cell killing through chemotherapy t...
NOV 20, 2018
Cell & Molecular Biology
NOV 20, 2018
A Warning About Using Epigenetic Modifiers as Therapeutic Targets
In the long run, some cancer therapeutics may be doing more harm than good....
NOV 20, 2018
Immunology
NOV 20, 2018
Mutations Mutations Which Ones Do We Want?
A team at UCSF makes use of new SLICE tool to generate mutations that reveal specific genetic functions....
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
DEC 18, 2018
Cancer
DEC 18, 2018
A new spray that can stop skin cancer recurrence and metastasis
Cancer recurrence and metastasis are the leading causes of death in cancer patients; this is why researchers at UCLA developed something that could help in stopping recurrence or metastasis i...
Loading Comments...